文献速递鼻科头颈外科

鼻腔鼻窦尤文肉瘤:范围综述

Ewing Sarcoma of the Sinonasal Tract: A Scoping Review.
PubMed 文献 · Laryngoscope · 2024-11-27

本范围综述检索了PubMed、Web of Science、SCOPUS、CINAHL和Cochrane Library,纳入72篇文章共93例鼻腔鼻窦尤文肉瘤病例。患者平均诊断年龄26.4岁(范围1-89),最常见症状为鼻塞(59%)、鼻出血(38%)和视力受损(29%)。手术联合辅助放化疗是最常用治疗方式(29%)。

要点

  • 鼻腔鼻窦尤文肉瘤患者平均诊断年龄26.4岁(范围1-89),男性占53%。
  • 最常见症状为鼻塞(59%)、鼻出血(38%)和视力受损(29%),41%患者检查发现鼻腔肿块。
  • 手术联合辅助放化疗是最常用治疗方式(29%),随访时60%患者无疾病证据。

核心结论

  • 据作者所知,这是首个鼻腔鼻窦尤文肉瘤的范围综述。
  • 患者通常表现为非特异性鼻腔鼻窦症状。
  • 手术联合辅助放化疗是这些患者最常用的治疗方式。

研究设计与样本

  • 范围综述,检索PubMed、Web of Science、SCOPUS、CINAHL和Cochrane Library。
  • 纳入标准为病例报告、病例系列或回顾性综述。
  • 共检索到785篇文章,72篇符合纳入标准,合计93例病例。

主要发现

  • 48例(53%)患者为男性,诊断时平均年龄26.4岁(范围1-89)。
  • 最常见症状为鼻塞(N=55,59%)、鼻出血(N=35,38%)和视力受损(N=29,29%)。
  • 检查时38例(41%)患者有鼻腔肿块,多数肿瘤(N=33,35%)位于上颌窦。
  • 44例(47%)为左侧,4例(4%)为双侧。
  • 最常用治疗方式为手术切除联合辅助放化疗(N=27,29%)、单纯放化疗(N=24,26%)和手术切除联合辅助化疗(N=14,15%)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Ewing sarcoma (ES) is a rare aggressive malignancy that can present in the sinonasal region. The objective of this study is to investigate the demographics, presentation, management, and outcomes of patients with sinonasal ES. DATA SOURCES: PubMed, Web of Science, SCOPUS, CINAHL, and Cochrane Library. REVIEW METHODS: A scoping review of cases of sinonasal ES was performed. Inclusion criteria consisted of case reports, series, or retrospective reviews. RESULTS: 785 total articles were retrieved. 72 articles met inclusion criteria and were included in the final review for a total of 93 cases. 48 (53%) patients were male. Mean age at diagnosis was 26.4 years old (range 1-89). Nasal obstruction (N = 55, 59%), epistaxis (N = 35, 38%), and impaired vision (N = 29, 29%) were the most common symptoms. On examination, 38 (41%) patients had a nasal cavity mass. Most tumors (N = 33, 35%) were located in the maxillary sinus. 44 (47%) were left sided and 4 (4%) were bilateral. The most utilized treatment modalities were surgical resection with adjuvant chemoradiotherapy (N = 27, 29%), chemoradiotherapy alone (N = 24, 26%), and surgical resection with adjuvant chemotherapy (N = 14, 15%). 56 patients had no evidence of disease (60%), 14 patients died with disease (15%), and 9 patients were alive with disease (10%) at the time of follow-up. CONCLUSIONS: To our knowledge, we report the first scoping review of sinonasal ES. Patients generally present with non-specific sinonasal symptoms. Surgery with adjuvant chemoradiation is the most common treatment modality for these patients. LEVEL OF EVIDENCE: NA Laryngoscope, 135:1571-1580, 2025.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Shaari AL, Ho R, Patel AM, et al. Ewing Sarcoma of the Sinonasal Tract: A Scoping Review. Laryngoscope. 2024. PMID: 39604591. doi:10.1002/lary.31925

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。